Also known as: Zolinza, suberoylanilide hydroxamic acid
Drug Information: Vorinostat is a new histone deacetylase inhibitor, a class of drugs that block specific enzymes and appear to have some role in suppressing malignant activity on the intracellular level. In the trial setting for indolent lymphoma, vorinostat has been taken orally, daily.
Showing posts with label Vorinostat. Show all posts
Showing posts with label Vorinostat. Show all posts
Wednesday, January 5, 2011
Subscribe to:
Posts (Atom)